References: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease NHLBI/WHO Workshop Report

1. National Heart, Lung, and Blood Institute. Morbidity & mortality: chartbook on cardiovascular, lung, and blood diseases. Bethesda, MD: US Department. of Health and Human Services, Public

Health Service, National Institutes of Health, 1998. Available from: URL: www.nhlbi.nih.gov/nhlbi/sei i n//other/cht -book/htm

2. Murray CJL, Lopez AD. Evidence-based health policy - lessons from the global burden of disease study. Science 1996; 274:740-3.

3. World health report. Geneva: World Health Organization, 2000. Available from: URL: http://www.who.int/en/

4. Hill AT, Bayley 0, Stockley RA. The interrelationship of sputum inflammatory markers in patients with chronic bronchitis. Am J Respir Crit Care Med 1999; 160:893-8.

5. Keatings VM, Collins PO, Scott OM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor­alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153:530-4.

6. Pesci A, Balbi B, Majori M, Cacciani G, Bertacco S, Alciato P, et al. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pul­monary disease. Eur Respir J 1998; 12:380-6.

7. Yamamoto C, Yoneda T, Yoshikawa M, Fu A, Tokuyama T, Tsukaguchi K, et al. Airway inflammation in COPD assessed by sputum levels of interleukin-8. Chest 1997; 112:505-10.

8. Mueller R, Chanez P, Campbell AM, Bousquet J, Heusser C, Bullock GR. Different cytokine patterns in bronchial biopsies in asthma and chronic bronchitis. Respir Med 1996; 90:79-85.

9. Mullen JB, Wright JL, Wiggs BR, Pare PO, Hogg JC. Reassessment of inflammation of airways in chronic bronchitis. BMJ 1985; 291: 1235-9.

10. Cosio M, Ghezzo H, Hogg JC, Corbin R, Loveland M, Dosman J, et al. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med 1978; 298: 1277 -81.

11. Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 1974; 291 :755-8.

12. Wright JL, Lawson LM, Pare PO, Wiggs BJ, Kennedy S, Hogg JC. Morphology of peripheral airways in current smokers and ex-smokers. Am Rev Respir Dis 1983; 127:474-7.

13. Ollerenshaw SL, Woolcock AJ. Characteristics of the inflammation in biopsies from large airways of subjects with asthma and subjects with chronic airflow limitation. Am Rev Respir Dis 1992; 145:922-7.

14. Hunninghake GW, Crystal RG. Cigarette smoking and lung destruction. Accumulation of neutrophils in the lungs of cigarette smokers. Am Rev Respir Dis 1983; 128:833-8. 15. Li XY, Brown 0, Smith S, MacNee W, Donaldson K. Short-term inflammatory responses following intratracheal instillation of fine and ultrafine carbon black in rats. Inhal Toxico/1999; 11:709-31.

16. Monn C, Becker S. Cytotoxicity and induction of proin­flammatory cytokines from human monocytes exposed to fine (PM2.5) and coarse particles (PM10-2.5) in outdoor and indoor air. Toxicol Appl Pharmaco/1999; 155:245-52.

17. Salvi S, Blomberg A, Rudell B, Kelly F, Sandstrom T, Holgate ST, et al. Acute inflammatory responses in the air­ways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers. Am J Respir Crit Care Med 1999; 159:702-9.

18. Von Essen SG, O'Neill DP, McGranaghan S, Olenchock SA, Rennard SI. Neutrophilic respiratory tract inflammation and peripheral blood neutrophilia after grain sorghum dust extract challenge. Chest 1995; 108:1425-33.

19. Von Essen SG, Robbins RA, Thompson AB, Ertl RF, Linder J, Rennard SI. Mechanisms of neutrophil recruit­ment to the lung by grain dust exposure [published erra­tum appears in Am Rev Respir Dis 1989;139:1065]. Am Rev Respir Dis 1988; 138:921-7.

20. O'Shaughnessy TC, Ansari TW, Barnes NC, Jeffery PK. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lympho­cytes with FEV 1. Am J Respir Crit Care Med 1997; 155:852-7.

21. Saetta M, Di Stefano A, Maestrelli P, Ferraresso A, Drigo R, Potena A, et al. Activated T-Iymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis 1993; 147:301-6.

22. Saetta M, Di Stefano A, Turato G, Facchini FM, Corbino L, Mapp CE, et al. CD8+ T-Iymphocytes in periph­eral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Moo 1998; 157:822-6.

23. Leopold JG, Goeff J. Cenbilobular fonn of hyper­trophic emphysema and its relation to chronic bronchitis. Thorax 1957; 12:219-35.

24. McLean KA. Pathogenesis of pulmonary emphysema. Am J Med 1958; 25:62-74.

25. Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. Am J Respir Crit Care Med 1997; 156:341-57.

26. Wright JL, Lawson L, Pare PO, Hooper RO, Peretz 01, Nelems JM, et al. The structure and function of the pul­monary vasculature in mild chronic obstructive pulmonary disease. The effect of oxygen and exercise. Am Rev Aespir Dis 1983; 128:702-7.

27. Peinado VI, Barbera JA, Abate P, Ramirez J, Roca J, Santos S, et al. Inflammatory reaction in pulmonary.mus­cular arteries of patients with mild chronic obstructive pul­monary disease. Am J Respir Crit Care Med 1999; 159:1605-11.

28. Riley OJ, Thakker-Varia S, Poiani GJ, Tozzi CA. Vascular remodeling. In: Crystal RG, West JB, Barnes PJ, Weibel ER, eds. The lung: scientific foundations. Philadelphia: Lippincott-Raven, 1977: 1589-97.

29. MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part two. Am J Respir Crit Care Med 1994; 150:1158-68.

30. Pride NB, Vermeire P, Allegra L. Diagnostic labels applied to model case histories of chronic airflow obstruc­tion. Responses to a questionnaire in 11 North American and Western European countries. Eur Respir J 1989; 2:702-9.

31. Mannino OM, Brown C, Giovino GA. Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data. Am J Respir Crit Care Med 1997; 156:814-8.

32. Murray CJL, Lopez AD, editors. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge, MA: Harvard University Press, 1996.

33. National Health Service Executive. Burden of dis­ease: a discussion document. London: Department of Health; 1996

34. Rutten-van Molken MP, Postma MJ, Joore MA, Van Genugten ML, Leidl R, Jager JC. Current and future medical costs of asthma and chronic obstructive pul­monary disease in The Netherlands. Respir Med 1999; 93:779-87.

35. Jacobson L, Hertzman P, Lofdahl C-G, Skoogh B-E, Lindgren B. The economic impact of asthma and COPD in Sweden 1980 and 1991. Respir Med 2000; 94:247-55. 36. Buist AS, Vollmer WM. Smoking and other risk fac­tors. In: Murray JF, Nadel JA, eds. Textbook of respirato­ry medicine. Philadelphia: WB Saunders Co, 1994: 1259­87.

37. Thom T J. International comparisons in COPD mortal­ity. Am Rev Respir Dis 1989; 140:S27-34.

38. Xu X, Weiss ST, Rijcken B, Schouten JP. Smoking, changes in smoking habits, and rate of decline in FEV1: new insight into gender differences. Eur Respir J 1994; 7:1056-61.

39. Feinleib M, Rosenberg HM, Collins JG, Delozier JE, Pokras R, Chevarley FM. Trends in COPD morbidity and mortality in the United States. Am Rev Respir Dis 1989; 140:S9-18.

40. US Centers for Disease Control and Prevention. Vital and health statistics: current estimates from the National Health Interview Survey. Department of Health and Human Services, Public Health Service, 1995. Publication No. 96-1527.

41. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, et al. Effects of smoking interven­tion and the use of an inhaled anticholinergic bron­chodilator on the rate of decline of FEV 1. The Lung Health Study. JAMA 1994; 272: 1497 -505.

42. Laurell CB, Eriksson S. The electrophoretic alpha-1 globulin pattern of serum in alpha-1 antitrypsin deficiency. Scand J Clin Lab Invest 1963; 15: 132-40. 43. Hubbard RC, Crystal RG. Antiproteases. In: Crystal RB, West JB, Barnes PJ, Cherniack NS, Weibel ER, eds. The lung: scientific foundations. New York: Raven Press, Ltd., 1991:1775-87.

44. McElvaney NG, Crystal RG. Inherited susceptibility of the lung to proteolytic injury. In: Crystal RG, West JB, Weibel ER, Barnes PJ, eds. The lung: scientific founda­tions. Philadelphia: Lippincott-Raven, 1997:2537-53.

45. Orie NGM, Sluiter HJ, De Vreis K, Tammerling K, Wikop J. The host factor in bronchitis. In: Orie NGM, Sluiter HG, eds. Bronchitis, an international symposium. Assen, Netherlands: Royal Vangorcum, 1961 :43-59.

46. Hagstrom B, Nyberg P, Nilsson PM. Asthma in adult life-is there an association with birth weight? ScandJ Prim Health Care 1998; 16:117-20.

47. Svanes C, Omenaas E, Heuch JM, Irgens LM, Gulsvik A. Birth characteristics and asthma symptoms in young adults: results from a population-based cohort study in Norway. Eur Respir J 1998; 12: 1366-70.

48. Todisco T, de Benedictis FM, lannacci L, Baglioni S, Eslami A, Todisco E, et al. Mild prematurity and respirato­ry functions. Eur J Pediatr 1993; 152:55-8.

49. Stein CE, Kumaran K, Fall CH, Shaheen SO, Osmond C, Barker DJ. Relation of fetal growth to adult lung function in South India. Thorax 1997; 52:895-9.

50. Morgan WJ. Maternal smoking and infant lung func­tion.  Further evidence for an in utero effect. Am J Respir Crit Care Med 1998; 158:689-90.

51. Tager IB, Segal MR, Speizer FE, Weiss S1. The nat­ural history of forced expiratory volumes. Effect of ciga­rette smoking and respiratory symptoms. Am Rev Respir Dis 1988; 138:837-49.

52. US Surgeon General. The health consequences of smoking: chronic obstructive pulmonary disease. Washington, DC: US Department of Health and Human Services, 1984. Publication No. 84-50205.

53. Leuenberger P, Schwartz J, Ackermann-Liebrich U, Blaser K, Bolognini G, Bongard JP, et al. Passive smok­ing exposure in adults and chronic respiratory symptoms (SAPALDIA Study). Swiss Study on Air Pollution and Lung Diseases in Adults, SAPALDIA Team. Am J Respir Crit Care Med 1994; 150:1222-8.

54. Dayal HH, Khuder S, Sharrar R, Trieff N. Passive smoking in obstructive respiratory disease in an industri­alized urban population. Environ Res 1994; 65:161-71.

55. Holt PG. Immune and inflammatory function in ciga­rette smokers. Thorax 1987; 42:241-9.

56. Kauffmann F, Drouet D, Lellouch J, Brille D. Twelve years spirometric changes among Paris area workers. Int J Epidemio/1979; 8:201-12.

57. Niewoehner DE. Anatomic and pathophysiological correlations in COPD. In: Baum GL, Crapo JD, Celli BR, Karlinsky JB, eds. Textbook of pulmonary diseases. Philadelphia: Lippincott-Raven, 1998:823-42.

58. Chen JC, Ma1mino MD. Worldwide epidemiology of chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine 1999; 5:93-9.

59. Perez-Padilla R, Regalado U, Vedal S, Pare P, Chapela R, Sansores R, et al. Exposure to biomass smoke and chronic airway disease in Mexican women. Am J Respir Crit Care Med 1996; 154:701-6.

60. Dossing M, Khan J, al-Rabiah F. Risk factors for chronic obstructive lung disease in Saudi Arabia. Respiratory Med 1994; 88:519-22.

61. Behera D, Jindal SK. Respiratory symptoms in Indian women using domestic cooking fuels. Chest 1991; 100:385-8.

62. Amoli K. Bronchopulmonary disease in Iranian housewives chronically exposed to indoor smoke. Eur Respir J 1998; 11 :659-63".

63. Dennis R, Maldonado D, Norman S, Baena E, Martinez G. Wood smoke exposure and risk for obstruc­tive airways disease among women. Chest 1996; 109:115-9.

64. Pandey MR. Prevalence of chronic bronchitis in a rural community of the Hill Region of Nepal. Thorax 1984; 39:331-6.

65. Pandey MR. Domestic smoke pollution and chronic bronchitis in a rural community of the Hill Region of Nepal. Thorax 1984; 39:337-9.

66. Samet JM, Marbury M, Spengler J. Health effects and sources of indoor air pollution. Am Rev Respir Dis 1987; 136:1486-508.

67. Tao X, Hong CJ, Yu S, Chen B, Zhu H, Yang M. Priority among air pollution factors for preventing chronic obstructive pulmonary disease in Shanghai. Sci Total Environ 1992; 127:57-67.

68. Prescott E, Lange P, Vestbo J. Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City

69. Strachan DP. Epidemiology: A British perspective. In: Calverley PMA, Pride NB, eds. Chronic obstructive pul­monary disease. London: Chapman and Hall, 1995:47-67. Heart Study. Eur Respir J 1999; 13:1109-14.